false
Hamburger Menu
Catalog
EP on EP Episode 76: Intersection of EP and CHF wi ...
EP on EP Episode 76: Intersection of EP and CHF with Clyde W. Yancy, MD, MSci
EP on EP Episode 76: Intersection of EP and CHF with Clyde W. Yancy, MD, MSci
Eric N. Prystowsky, MD, FHRS, sits down with Silvia G Priori, MD, PhD, to discuss gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia (CPVT).
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered
×
EP on EP Episode 76: Intersection of EP and CHF with Clyde W. Yancy, MD, MSci Course List
Recommended
Learning Activity Title
Learning Activity Title
Learning Activity Title
EP Fellows Curriculum: Electroanatomic Mapping 101
No Credit
FREE
(2)
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Case Base
No Credit
FREE
(2)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Abstract Catalog 2025: ePosters
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
EP on EP Episode 104: Primary Prevention of SCD Revisited
No Credit
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Lead Episode 80: Catheter Ablation versus Advanced Therapy for Patients with Severe Heart Failure and Ventricular Electrical Storm
Multiple Credits
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Beat Webinar Series - Live from APHRS in Sydney: HRS-APHRS Joint Session Update on Conduction System Pacing 2024: Current Controversies.
No Credit
FREE
(1)
Learning Activity Title
Learning Activity Title
Learning Activity Title
EP on EP Episode 107: ER2EP - Eliminating the Middle Man for AF
No Credit
FREE
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Forgot Password
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English